Click for best price
Noninvasive Cancer Diagnosis Market Size, Share 2022
This report contains market size and forecasts of Non-invasive Cancer Diagnosis in Global, including the following market information:
Global Non-invasive Cancer Diagnosis Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Non-invasive Cancer Diagnosis market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Clinical Chemistry Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Non-invasive Cancer Diagnosis include Gen-Probe Inc., A&G Pharmaceutical, Affymetrix Inc., Digene Corporation, Quest Diagnostics Inc., BioView Inc., LabCorp, AVIVA Biosciences Corporation and Precision Therapeutics. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Non-invasive Cancer Diagnosis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non-invasive Cancer Diagnosis Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Non-invasive Cancer Diagnosis Market Segment Percentages, by Type, 2021 (%)
Clinical Chemistry
Immunochemistry/Immunoassay
Molecular Diagnostics
Others
Global Non-invasive Cancer Diagnosis Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Non-invasive Cancer Diagnosis Market Segment Percentages, by Application, 2021 (%)
Blood Cancer
Solid Tumors
Breast Cancer
Lung Cancer
Others
Global Non-invasive Cancer Diagnosis Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Non-invasive Cancer Diagnosis Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Non-invasive Cancer Diagnosis revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Non-invasive Cancer Diagnosis revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Gen-Probe Inc.
A&G Pharmaceutical
Affymetrix Inc.
Digene Corporation
Quest Diagnostics Inc.
BioView Inc.
LabCorp
AVIVA Biosciences Corporation
Precision Therapeutics
| Report Attributes |
Report Details |
| Report Title |
Non-invasive Cancer Diagnosis Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
63 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Non-invasive Cancer Diagnosis Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-invasive Cancer Diagnosis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non-invasive Cancer Diagnosis Overall Market Size
2.1 Global Non-invasive Cancer Diagnosis Market Size: 2021 VS 2028
2.2 Global Non-invasive Cancer Diagnosis Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Non-invasive Cancer Diagnosis Players in Global Market
3.2 Top Global Non-invasive Cancer Diagnosis Companies Ranked by Revenue
3.3 Global Non-invasive Cancer Diagnosis Revenue by Companies
3.4 Top 3 and Top 5 Non-invasive Cancer Diagnosis Companies in Global Market, by Revenue in 2021
3.5 Global Companies Non-invasive Cancer Diagnosis Product Type
3.6 Tier 1, Tier 2 and Tier 3 Non-invasive Cancer Diagnosis Players in Global Market
3.6.1 List of Global Tier 1 Non-invasive Cancer Diagnosis Companies
3.6.2 List of Global Tier 2 and Tier 3 Non-invasive Cancer Diagnosis Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Non-invasive Cancer Diagnosis Market Size Markets, 2021 & 2028
4.1.2 Clinical Chemistry
4.1.3 Immunochemistry/Immunoassay
4.1.4 Molecular Diagnostics
4.1.5 Others
4.2 By Type - Global Non-invasive Cancer Diagnosis Revenue & Forecasts
4.2.1 By Type - Global Non-invasive Cancer Diagnosis Revenue, 2017-2022
4.2.2 By Type - Global Non-invasive Cancer Diagnosis Revenue, 2023-2028
4.2.3 By Type - Global Non-invasive Cancer Diagnosis Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Non-invasive Cancer Diagnosis Market Size, 2021 & 2028
5.1.2 Blood Cancer
5.1.3 Solid Tumors
5.1.4 Breast Cancer
5.1.5 Lung Cancer
5.1.6 Others
5.2 By Application - Global Non-invasive Cancer Diagnosis Revenue & Forecasts
5.2.1 By Application - Global Non-invasive Cancer Diagnosis Revenue, 2017-2022
5.2.2 By Application - Global Non-invasive Cancer Diagnosis Revenue, 2023-2028
5.2.3 By Application - Global Non-invasive Cancer Diagnosis Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Non-invasive Cancer Diagnosis Market Size, 2021 & 2028
6.2 By Region - Global Non-invasive Cancer Diagnosis Revenue & Forecasts
6.2.1 By Region - Global Non-invasive Cancer Diagnosis Revenue, 2017-2022
6.2.2 By Region - Global Non-invasive Cancer Diagnosis Revenue, 2023-2028
6.2.3 By Region - Global Non-invasive Cancer Diagnosis Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Non-invasive Cancer Diagnosis Revenue, 2017-2028
6.3.2 US Non-invasive Cancer Diagnosis Market Size, 2017-2028
6.3.3 Canada Non-invasive Cancer Diagnosis Market Size, 2017-2028
6.3.4 Mexico Non-invasive Cancer Diagnosis Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Non-invasive Cancer Diagnosis Revenue, 2017-2028
6.4.2 Germany Non-invasive Cancer Diagnosis Market Size, 2017-2028
6.4.3 France Non-invasive Cancer Diagnosis Market Size, 2017-2028
6.4.4 U.K. Non-invasive Cancer Diagnosis Market Size, 2017-2028
6.4.5 Italy Non-invasive Cancer Diagnosis Market Size, 2017-2028
6.4.6 Russia Non-invasive Cancer Diagnosis Market Size, 2017-2028
6.4.7 Nordic Countries Non-invasive Cancer Diagnosis Market Size, 2017-2028
6.4.8 Benelux Non-invasive Cancer Diagnosis Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Non-invasive Cancer Diagnosis Revenue, 2017-2028
6.5.2 China Non-invasive Cancer Diagnosis Market Size, 2017-2028
6.5.3 Japan Non-invasive Cancer Diagnosis Market Size, 2017-2028
6.5.4 South Korea Non-invasive Cancer Diagnosis Market Size, 2017-2028
6.5.5 Southeast Asia Non-invasive Cancer Diagnosis Market Size, 2017-2028
6.5.6 India Non-invasive Cancer Diagnosis Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Non-invasive Cancer Diagnosis Revenue, 2017-2028
6.6.2 Brazil Non-invasive Cancer Diagnosis Market Size, 2017-2028
6.6.3 Argentina Non-invasive Cancer Diagnosis Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Non-invasive Cancer Diagnosis Revenue, 2017-2028
6.7.2 Turkey Non-invasive Cancer Diagnosis Market Size, 2017-2028
6.7.3 Israel Non-invasive Cancer Diagnosis Market Size, 2017-2028
6.7.4 Saudi Arabia Non-invasive Cancer Diagnosis Market Size, 2017-2028
6.7.5 UAE Non-invasive Cancer Diagnosis Market Size, 2017-2028
7 Players Profiles
7.1 Gen-Probe Inc.
7.1.1 Gen-Probe Inc. Corporate Summary
7.1.2 Gen-Probe Inc. Business Overview
7.1.3 Gen-Probe Inc. Non-invasive Cancer Diagnosis Major Product Offerings
7.1.4 Gen-Probe Inc. Non-invasive Cancer Diagnosis Revenue in Global Market (2017-2022)
7.1.5 Gen-Probe Inc. Key News
7.2 A&G Pharmaceutical
7.2.1 A&G Pharmaceutical Corporate Summary
7.2.2 A&G Pharmaceutical Business Overview
7.2.3 A&G Pharmaceutical Non-invasive Cancer Diagnosis Major Product Offerings
7.2.4 A&G Pharmaceutical Non-invasive Cancer Diagnosis Revenue in Global Market (2017-2022)
7.2.5 A&G Pharmaceutical Key News
7.3 Affymetrix Inc.
7.3.1 Affymetrix Inc. Corporate Summary
7.3.2 Affymetrix Inc. Business Overview
7.3.3 Affymetrix Inc. Non-invasive Cancer Diagnosis Major Product Offerings
7.3.4 Affymetrix Inc. Non-invasive Cancer Diagnosis Revenue in Global Market (2017-2022)
7.3.5 Affymetrix Inc. Key News
7.4 Digene Corporation
7.4.1 Digene Corporation Corporate Summary
7.4.2 Digene Corporation Business Overview
7.4.3 Digene Corporation Non-invasive Cancer Diagnosis Major Product Offerings
7.4.4 Digene Corporation Non-invasive Cancer Diagnosis Revenue in Global Market (2017-2022)
7.4.5 Digene Corporation Key News
7.5 Quest Diagnostics Inc.
7.5.1 Quest Diagnostics Inc. Corporate Summary
7.5.2 Quest Diagnostics Inc. Business Overview
7.5.3 Quest Diagnostics Inc. Non-invasive Cancer Diagnosis Major Product Offerings
7.5.4 Quest Diagnostics Inc. Non-invasive Cancer Diagnosis Revenue in Global Market (2017-2022)
7.5.5 Quest Diagnostics Inc. Key News
7.6 BioView Inc.
7.6.1 BioView Inc. Corporate Summary
7.6.2 BioView Inc. Business Overview
7.6.3 BioView Inc. Non-invasive Cancer Diagnosis Major Product Offerings
7.6.4 BioView Inc. Non-invasive Cancer Diagnosis Revenue in Global Market (2017-2022)
7.6.5 BioView Inc. Key News
7.7 LabCorp
7.7.1 LabCorp Corporate Summary
7.7.2 LabCorp Business Overview
7.7.3 LabCorp Non-invasive Cancer Diagnosis Major Product Offerings
7.7.4 LabCorp Non-invasive Cancer Diagnosis Revenue in Global Market (2017-2022)
7.7.5 LabCorp Key News
7.8 AVIVA Biosciences Corporation
7.8.1 AVIVA Biosciences Corporation Corporate Summary
7.8.2 AVIVA Biosciences Corporation Business Overview
7.8.3 AVIVA Biosciences Corporation Non-invasive Cancer Diagnosis Major Product Offerings
7.8.4 AVIVA Biosciences Corporation Non-invasive Cancer Diagnosis Revenue in Global Market (2017-2022)
7.8.5 AVIVA Biosciences Corporation Key News
7.9 Precision Therapeutics
7.9.1 Precision Therapeutics Corporate Summary
7.9.2 Precision Therapeutics Business Overview
7.9.3 Precision Therapeutics Non-invasive Cancer Diagnosis Major Product Offerings
7.9.4 Precision Therapeutics Non-invasive Cancer Diagnosis Revenue in Global Market (2017-2022)
7.9.5 Precision Therapeutics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Non-invasive Cancer Diagnosis Market Opportunities & Trends in Global Market
Table 2. Non-invasive Cancer Diagnosis Market Drivers in Global Market
Table 3. Non-invasive Cancer Diagnosis Market Restraints in Global Market
Table 4. Key Players of Non-invasive Cancer Diagnosis in Global Market
Table 5. Top Non-invasive Cancer Diagnosis Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Non-invasive Cancer Diagnosis Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Non-invasive Cancer Diagnosis Revenue Share by Companies, 2017-2022
Table 8. Global Companies Non-invasive Cancer Diagnosis Product Type
Table 9. List of Global Tier 1 Non-invasive Cancer Diagnosis Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non-invasive Cancer Diagnosis Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Non-invasive Cancer Diagnosis Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Non-invasive Cancer Diagnosis Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Non-invasive Cancer Diagnosis Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Non-invasive Cancer Diagnosis Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Non-invasive Cancer Diagnosis Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Non-invasive Cancer Diagnosis Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2023-2028
Table 30. Gen-Probe Inc. Corporate Summary
Table 31. Gen-Probe Inc. Non-invasive Cancer Diagnosis Product Offerings
Table 32. Gen-Probe Inc. Non-invasive Cancer Diagnosis Revenue (US$, Mn), (2017-2022)
Table 33. A&G Pharmaceutical Corporate Summary
Table 34. A&G Pharmaceutical Non-invasive Cancer Diagnosis Product Offerings
Table 35. A&G Pharmaceutical Non-invasive Cancer Diagnosis Revenue (US$, Mn), (2017-2022)
Table 36. Affymetrix Inc. Corporate Summary
Table 37. Affymetrix Inc. Non-invasive Cancer Diagnosis Product Offerings
Table 38. Affymetrix Inc. Non-invasive Cancer Diagnosis Revenue (US$, Mn), (2017-2022)
Table 39. Digene Corporation Corporate Summary
Table 40. Digene Corporation Non-invasive Cancer Diagnosis Product Offerings
Table 41. Digene Corporation Non-invasive Cancer Diagnosis Revenue (US$, Mn), (2017-2022)
Table 42. Quest Diagnostics Inc. Corporate Summary
Table 43. Quest Diagnostics Inc. Non-invasive Cancer Diagnosis Product Offerings
Table 44. Quest Diagnostics Inc. Non-invasive Cancer Diagnosis Revenue (US$, Mn), (2017-2022)
Table 45. BioView Inc. Corporate Summary
Table 46. BioView Inc. Non-invasive Cancer Diagnosis Product Offerings
Table 47. BioView Inc. Non-invasive Cancer Diagnosis Revenue (US$, Mn), (2017-2022)
Table 48. LabCorp Corporate Summary
Table 49. LabCorp Non-invasive Cancer Diagnosis Product Offerings
Table 50. LabCorp Non-invasive Cancer Diagnosis Revenue (US$, Mn), (2017-2022)
Table 51. AVIVA Biosciences Corporation Corporate Summary
Table 52. AVIVA Biosciences Corporation Non-invasive Cancer Diagnosis Product Offerings
Table 53. AVIVA Biosciences Corporation Non-invasive Cancer Diagnosis Revenue (US$, Mn), (2017-2022)
Table 54. Precision Therapeutics Corporate Summary
Table 55. Precision Therapeutics Non-invasive Cancer Diagnosis Product Offerings
Table 56. Precision Therapeutics Non-invasive Cancer Diagnosis Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Non-invasive Cancer Diagnosis Segment by Type in 2021
Figure 2. Non-invasive Cancer Diagnosis Segment by Application in 2021
Figure 3. Global Non-invasive Cancer Diagnosis Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Non-invasive Cancer Diagnosis Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Non-invasive Cancer Diagnosis Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Non-invasive Cancer Diagnosis Revenue in 2021
Figure 8. By Type - Global Non-invasive Cancer Diagnosis Revenue Market Share, 2017-2028
Figure 9. By Application - Global Non-invasive Cancer Diagnosis Revenue Market Share, 2017-2028
Figure 10. By Region - Global Non-invasive Cancer Diagnosis Revenue Market Share, 2017-2028
Figure 11. By Country - North America Non-invasive Cancer Diagnosis Revenue Market Share, 2017-2028
Figure 12. US Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Non-invasive Cancer Diagnosis Revenue Market Share, 2017-2028
Figure 16. Germany Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 17. France Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Non-invasive Cancer Diagnosis Revenue Market Share, 2017-2028
Figure 24. China Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 28. India Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Non-invasive Cancer Diagnosis Revenue Market Share, 2017-2028
Figure 30. Brazil Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Non-invasive Cancer Diagnosis Revenue Market Share, 2017-2028
Figure 33. Turkey Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 37. Gen-Probe Inc. Non-invasive Cancer Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. A&G Pharmaceutical Non-invasive Cancer Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Affymetrix Inc. Non-invasive Cancer Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Digene Corporation Non-invasive Cancer Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Quest Diagnostics Inc. Non-invasive Cancer Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. BioView Inc. Non-invasive Cancer Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. LabCorp Non-invasive Cancer Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. AVIVA Biosciences Corporation Non-invasive Cancer Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Precision Therapeutics Non-invasive Cancer Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
